Bausch HealthBHC
About: Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Employees: 20,270
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0% less funds holding
Funds holding: 231 [Q1] → 230 (-1) [Q2]
0.48% less ownership
Funds ownership: 76.99% [Q1] → 76.51% (-0.48%) [Q2]
3% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 40
18% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 71
30% less funds holding in top 10
Funds holding in top 10: 10 [Q1] → 7 (-3) [Q2]
33% less capital invested
Capital invested by funds: $2.93B [Q1] → $1.96B (-$972M) [Q2]
72% less call options, than puts
Call options by funds: $34.3M | Put options by funds: $124M
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
RBC Capital Douglas Miehm 86% 1-year accuracy 6 / 7 met price target | 4%upside $8.50 | Sector Perform Maintained | 2 Aug 2024 |
Piper Sandler David Amsellem 64% 1-year accuracy 23 / 36 met price target | 63%downside $3 | Underweight Downgraded | 2 Aug 2024 |
Truist Securities Gregory Fraser 50% 1-year accuracy 3 / 6 met price target | 14%downside $7 | Hold Maintained | 25 Jul 2024 |
Financial journalist opinion
Based on 12 articles about BHC published over the past 30 days